PulseJournal ClubResearchersJournalsExplore
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
April 28, 2026SHILAP Revista de lepidopterologíaOpen Access

A decade of breakthroughs: ten years of immunotherapy for lung cancer patients in Poland

View Full Paper
Ask AI
Bookmark
Share

Authors

APA Pluzanski

Discussion

Loading...

Member takes

Overview

Chronological review reveals improvements in treatment for lung cancer patients via immunotherapy, enhancing outcomes and access.

Key Points

  • The review aims to detail advancements in immunotherapy for non-small cell lung cancer in Poland over the past decade.
  • Conducted a chronological review identifying four key stages of immunotherapy implementation.
  • Examined the evolution from palliative care in advanced disease to curative strategies in early-stage disease.
  • Analyzed the impact of reimbursement under drug program B.6 on treatment access and quality.
  • Identified four key stages of immunotherapy development: second-line therapy breakthrough, first-line treatment evolution, consolidation and combination therapies, and perioperative treatment shifts.
  • Noted improved treatment outcomes due to expanded access resulting from drug program B.6 reimbursement.
  • Demonstrated a shift from palliative to curative intent in treatment strategies for lung cancer patients.

Cite This Study

A Pluzanski (2026) studied this question.

synapsesocial.com/papers/69f04e9b727298f751e728d1https://doi.org/10.5603/ocp.111650
View Full Paper
Ask AI
Bookmark
Share